Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J’s Risperdal Consta No Better Than Cheaper Drugs in Study
J&J’s Risperdal Consta No Better Than Cheaper Drugs in Study
J&J’s Risperdal Consta No Better Than Cheaper Drugs in Study
Submitted by
admin
on March 3, 2011 - 11:20am
Source:
Bloomberg
News Tags:
JNJ
Risperdal Consta
schizophrenia
antipsychotics
Headline:
J&J’s Risperdal Consta No Better Than Cheaper Drugs in Study
Do Not Allow Advertisers to Use My Personal information
